Infect Immun, March 1998, p. 944-949, Vol. 66, No. 3
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Sections for Molecular Pathogenesis,1 Immunology,2 and Connective Tissue Biology,3 Department of Cell and Molecular Biology, Lund University, S-221 00 Lund, Sweden
Received 4 September 1997/Returned for modification 22 October 1997/Accepted 10 December 1997
| |
ABSTRACT |
|---|
|
|
|---|
Curli are thin, coiled fibers expressed on the surface of
Escherichia coli that bind several matrix and plasma
proteins such as fibronectin, laminin, plasminogen, tissue plasminogen
activator, and H-kininogen. In this work, we examined the interactions
between curli-expressing E. coli and human major
histocompatibility complex class I (MHC-I) and class II (MHC-II)
molecules. Curliated E. coli was found to interact with an
MHC-I-expressing lymphoma cell line as shown by scanning electron
microscopy, whereas the binding to a mutant variant of this cell line
expressing small amounts of MHC-I molecules was significantly lower.
Moreover, curli-expressing E. coli bound purified
radiolabeled MHC-I but not MHC-II molecules, whereas an isogenic
curli-deficient mutant strain showed no affinity for either MHC-I or
MHC-II. Purified insoluble curli could also bind
125I-labeled MHC-I molecules, and in Western blot
experiments the 15-kDa curlin subunit protein bound intact MHC-I
molecules as well as
2-microglobulin, the light chain of
MHC-I molecules. A direct interaction between monomeric MHC-I molecules
and a bacterial surface protein has previously not been reported. The
binding of curli to MHC-I molecules, which are present on virtually all cells in higher vertebrates, will provide curliated E. coli
with ample opportunities to interact with a great variety of hosts and
host cells. This should facilitate the adaptation of E. coli to different ecological niches, and in human infections the
interaction between curli and MHC-I molecules could contribute to
adherence and colonization.
| |
INTRODUCTION |
|---|
|
|
|---|
Some Escherichia coli strains belonging to different clinical types (enterotoxigenic, enterohemorrhagic, and sepsis isolates) express fibrous surface proteins called curli (3, 23). Similar surface organelles designated thin aggregative fimbriae are also found in Salmonella enteritidis (6-8). Curli fimbriae in E. coli consist of polymers of a single 15-kDa protein encoded by the curlin subunit gene csgA (23), which is highly homologous to the AgfA subunit in thin aggregative fimbriae (6, 10). For simplicity, curli fimbriae are referred to here as curli. The production of curli in E. coli requires expression of two csg operons (15), and the polymerization of the curlin subunit to insoluble curli is dependent on the presence of a specific nucleator protein encoded by the csgB gene (16). The csgA and csgB genes are cotranscribed (1), and they show 25% sequence identity at the protein level. A prominent and noteworthy property of curli polymers is their ability to specifically interact with numerous human proteins such as the matrix proteins fibronectin and laminin (23, 24) and proteins of the fibrinolytic and contact-phase systems (3, 26). This ability should facilitate the adaptation of curli-expressing bacteria to different niches in the infected host.
Major histocompatibility complex (MHC) class I (MHC-I) molecules are
highly polymorphic transmembrane glycoproteins (for references, see
reference 14). They function as receptors that
present foreign peptides to cytolytic T cells, resulting in the
destruction of the presenting cell, i.e., a virus-infected cell.
Structurally, MHC-I molecules are composed of a 40-kDa heavy chain
which has three extracellular globular domains, a short transmembrane
domain, and a cytoplasmic domain (5). The 12-kDa light
chain,
2-microglobulin (
2m), is
noncovalently associated with the three extracellular globular domains
of the heavy chain.
2m and these domains all exhibit the
typical immunoglobulin (Ig) fold (28), and consequently MHC-I molecules belong to the Ig superfamily of proteins. Numerous Ig-binding bacterial surface proteins have been isolated and
characterized (for references, see reference 18).
However, none of these or any other defined microbial surface protein
has been reported to interact directly with monomeric MHC-I molecules.
As these Ig-related surface proteins are found at the surface of all
nucleated mammalian cells, this is somewhat surprising. Thus, it would
appear a plausible microbial strategy to adhere to these abundant
surface proteins during, for instance, the initial colonization of the host. This notion and the multipotent protein-binding property of curli
stimulated us to analyze a possible interaction between MHC-I molecules
and curli. The results demonstrate that curliated E. coli,
purified curli, and the curlin subunit protein indeed have affinity for
MHC-I molecules.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Bacterial strains. E. coli strains used in this study are the curli-proficient strain YMel and the curli-deficient isogenic mutant strain YMel-1 (23). Different clinical isolates from various gastrointestinal infections (3) were kindly provided by James P. Nataro, University of Maryland School of Medicine, Baltimore, Md. To obtain maximal curli expression, the bacteria were grown on colony factor antigen-agar plates (12) for approximately 40 h at 26°C.
MHC molecules and curli.
Purified papain-solubilized human
MHC-I molecules (HLA-A, -B, and -C) and detergent-solubilized MHC-II
molecules (HLA-DR) were kindly provided by Lars Rask and Johan
Sundelin, Department of Medical and Physiological Chemistry, Uppsala
University, Uppsala, Sweden. Details concerning these preparations
isolated from pooled spleens have been published elsewhere (19,
27). Human
2m was purified in this laboratory
(4). Curli were purified as described elsewhere
(8).
Radiolabeling of proteins. Proteins were radiolabeled as described by Hunter and Greenwood (17); 100 µg of protein was mixed with 0.5 mCi of 125I (Amersham, Arlington Heights, Ill.) and oxidized with 20 µg of chloramine T (Sigma, St. Louis, Mo.).
Bacterial binding and inhibition assays.
Bacterial binding
and inhibition analyses were performed as previously described
(26). Briefly, bacteria were resuspended in
phosphate-buffered saline (PBS; 0.15 M NaCl, 0.06 M phosphate [pH
7.2]) containing 0.1% Tween 20 to a concentration of 1010
cells ml
1. Dilutions of the bacteria were incubated with
125I-labeled protein (50 to 100 ng) in a total volume of
250 µl in polypropylene tubes at 20 or 37°C for 1 h. For the
inhibition experiments, the radiolabeled protein was mixed with the
unlabeled competitor proteins to be tested. After incubation, the
bacteria were washed once in 2 ml of PBS containing 0.1% Tween 20. The radioactivity associated with the pellet was determined after a brief
centrifugation. Binding was expressed as the percentage of the added
radioactivity, deducting the nonspecific uptake to the propylene tubes.
Binding of MHC-I molecules to purified curli. Purified curli preparations from YMel appearing as insoluble aggregates were incubated with 100 ng of 125I-labeled MHC-I molecules for 18 h at room temperature. After incubation, samples were centrifuged at 15,800 × g for 10 min and the supernatants were collected. The pellets were washed three times in PBS, resuspended in 20 µl of sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) sample buffer, boiled, and centrifuged. The supernatants were subjected to SDS-PAGE.
SDS-PAGE and Western blot experiments.
SDS-PAGE was
performed as described previously (20), and separated
proteins were transferred onto polyvinylidene fluoride Immobilon-P
membranes (Millipore, Bedford, Mass.). Membranes were incubated with
blocking buffer (PBS containing 0.25% [wt/vol] Tween 20 and 0.25%
[wt/vol] bovine serum albumin) at room temperature. The
125I-labeled proteins (
6 × 106 cpm)
were added followed by incubation at 4°C overnight. As molecular weight markers, prestained Kaleidoscope standard proteins (Bio-Rad, Hercules, Calif.) were used. The membrane was extensively washed in
blocking buffer, dried, and exposed to X-ray film (Kodak, Rochester, N.Y.).
Cell culture conditions. RMA and RMA-S cells were kindly provided by Klas Kärre, Microbiology and Tumor Biology Center, Karolinska Institute, Stockholm, Sweden. RMA and RMA-S cells were grown in Iscove's modified Dulbecco's medium (IMDM; Gibco BRL, Gaithersburg, Md.) supplemented with 5% fetal calf serum and antibiotics and cultured at 37°C in a 5% CO2 atmosphere. Detroit 562 (ATCC CCL 138) cells were grown in minimal essential medium (Gibco) supplemented with 0.1 mM glutamine and 10% fetal calf serum in a 5% CO2 atmosphere.
SEM. For scanning electron microscopy (SEM), 100 µl of lymphoma cell suspension containing approximately 5 × 105 cells in IMDM was added on top of a wet Nylaflo 0.2-µm-pore-size membrane (German Sciences, Ann Arbor, Mich.). The sample was gently drawn onto the filter by suction caused by prewetted filter paper lying underneath the Nylaflo filter. The filter was fixed in 2% glutaraldehyde in 0.1 M sodium cacodylate-0.1 M sucrose (pH 7.2) for 1 h at 4°C and was then washed with 0.15 M cacodylate buffer (pH 7.2); 100 µl of a bacterial suspension in PBS containing approximately 107 bacteria was added on top of the fixed cells and allowed to interact for 1 h at room temperature. The filters were then washed with cacodylate buffer, fixed in 2% glutaraldehyde in 0.1 M sodium cacodylate-0.1 M sucrose (pH 7.2) for 1 h at 4°C, and washed with cacodylate buffer. Finally, the filters were postfixed in 1% osmium tetroxide in 0.15 M sodium cacodylate (pH 7.2) for 1 h at 4°C, washed, and stored in cacodylate buffer. Fixed filter paper samples were dehydrated for 10 min at each step of an ascending ethanol series and inserted into a Balzers critical point dryer, using 100% ethanol as the intermediate solvent. The high-pressure chamber was then extensively flushed three times for 30 min with carbon dioxide to remove all traces of residual ethanol, and the samples were critical point dried, mounted on aluminum holders, palladium-gold sputtered, and examined in a Jeol JSM-T330 SEM.
For each bacterium-cell pair, five separate fields of approximately 80 to 200 cells were counted. Cells with attached bacteria were scored positive. Student's t test was used for statistical analysis. Data are presented as mean ± standard deviation (SD).| |
RESULTS |
|---|
|
|
|---|
E. coli bacteria expressing curli bind human MHC-I
molecules.
E. coli YMel grown in vitro at 26°C expresses
curli, a surface organelle composed of a 15-kDa curlin subunit. To
investigate whether curli-expressing bacteria interact with human MHC
molecules, purified MHC-I and MHC-II molecules were radiolabeled and
tested for binding to YMel bacteria. These bacteria bound 60 to 70% of the added 125I-labeled MHC-I but less than 10% of MHC-II
molecules (Fig. 1). We detected no
binding of 125I-labeled MHC-I or MHC-II molecules to the
isogenic mutant E. coli YMel-1 strain, which has an
inactivated curlin subunit gene and lacks curli on its surface
(23). When the same E. coli strains were
incubated with 125I-labeled
2m, the light
chain of MHC-I molecules, YMel bound 25 to 30% of the added protein
(Fig. 1) whereas the curli-deficient strain YMel-1 showed no binding.
The results demonstrate that curliated bacteria interact with intact
MHC-I molecules and to a lesser extent also with the isolated light
chain,
2m. In these experiments, the same results were
obtained when the binding assays were performed at room temperature
(Fig. 1) and at 37°C (data not shown). However, as mentioned above,
curli expression in vitro is regulated by temperature, and curli are
not expressed when YMel is grown at 37°C (2, 24). When
grown at 37°C, YMel showed no binding of MHC-I molecules or
2m (data not shown), emphasizing that curli are
responsible for the interaction between E. coli and MHC-I
molecules. A collection of 19 E. coli isolates belonging to
different clinical types previously tested for curli expression (3) was also analyzed in binding experiments with
radiolabeled MHC-I molecules. The 7 curliated isolates all showed
affinity for MHC-I, whereas none of the 12 nonexpressing isolates bound the added radiolabeled protein above background level (data not shown).
|
2m and fibronectin
partially inhibited the binding, reducing it to
75 and 25%,
respectively, of the level of binding in the presence of albumin. These
data suggest that the curli-MHC-I interaction is specific and that the
binding sites for fibronectin and
2m on curli partially
overlap or are located close to the binding site for intact MHC-I
molecules. These results together with the data in Fig. 1, 3, and 4
(see below) suggest that MHC-I molecules interact with curli through both
2m and the heavy chain of MHC-I molecules. The data
also suggest that the affinity is higher for intact MHC-I molecules than for
2m.
|
Purified curlin subunit protein binds MHC-I molecules.
Curli
are large insoluble polymers of curlin subunits. Formic acid treatment
of purified intact curli organelles releases the subunit (8,
23), which migrates as a single band of 15 kDa when subjected to
SDS-PAGE. The experiments summarized in Fig. 3 were set up to analyze
whether purified curlin subunits have affinity for MHC-I molecules
and/or
2m.
2m (Fig. 3b and c, respectively). The results
demonstrate that both probes bind to curlin subunits with a high degree
of specificity. None of the other proteins solubilized from curliated E. coli bacteria with SDS-PAGE sample buffer reacted with
the probes. Again, the stronger signal seen with MHC-I suggests a higher affinity for intact MHC-I than for
2m.
|
Insoluble curli aggregates bind MHC-I molecules. Purified curli organelles appear as insoluble aggregates (8, 23). We therefore investigated whether such purified insoluble aggregates were capable of binding MHC-I in vitro. Papain-solubilized MHC-I preparations from human spleens are typically size heterogeneous, with two dominating bands of 36 and 12 kDa corresponding to the MHC-I heavy and light chains, respectively. 125I-labeled MHC-I molecules (Fig. 4, lane A) were incubated with insoluble curli aggregates; following incubation, the aggregates were centrifuged and washed carefully. Ninety percent of the radioactivity was found to be associated with the pellet. This radioactivity was released by boiling the aggregates in SDS-PAGE sample buffer and subjecting them to SDS-PAGE followed by autoradiography. Two major bands of approximately 36 and 12 kDa were released from the curli aggregates preincubated with 125I-MHC-I molecules (Fig. 4, lane B), demonstrating that purified native curli bind MHC-I molecules.
|
Curliated E. coli bacteria adhere to MHC-I-expressing
cells.
The observation that curli bound purified MHC-I molecules
raised the question of whether mammalian cells could interact with curliated bacteria through MHC-I molecules. SEM revealed that curliated
bacteria adhered better than noncurliated bacteria to the human
epithelial cell line Detroit 562 (mean numbers of bacteria adhering/cell were 1.7 for YMel and
0.1 for YMel-1). However, to test
our hypothesis more conclusively, the MHC-I-expressing mouse lymphoma
cell line RMA (21) and its mutant variant RMA-S, which
expresses less than 10% of the MHC-I level of RMA (21), were used in adhesion experiments. Curliated YMel bacteria and the
isogenic mutant strain YMel-1 were incubated separately with RMA or
RMA-S cells, and interactions between bacteria and eukaryotic cells
were analyzed by SEM. These studies revealed that YMel bacteria adhered
to the MHC-I-expressing RMA cells (Fig.
5A) whereas noncurliated YMel-1 did not
(Fig. 5B). When YMel and YMel-1 bacteria were incubated with
MHC-I-negative RMA-S cells, no significant binding was detected (Fig.
5C and D). The mean number of bacteria attached to RMA and RMA-S cells
demonstrated that curliated YMel bacteria adhered more efficiently to
RMA cells than did YMel-1 bacteria (mean values, 6.3 and 0.7 bacteria/RMA cell, respectively), whereas no significant difference was
recorded when RMA-S cells were used (mean values, 0.8 and 0.3 bacterium/RMA-S cell). The expression of MHC-I is higher in lymphocytes
than in epithelial cells (11, 13), which is consistent with
the observation that curliated bacteria adhere better to RMA cells than
to Detroit 562 cells. Furthermore, as shown in Fig. 5E, the percentage
of RMA cells with adhering YMel bacteria was significantly higher than
the percentage of RMA cells that bound noncurliated YMel-1 (91.2% ± 1.9%, compared to 14.3% ± 3.8%; P < 0.001). In
contrast, no statistically significant difference in the binding of
YMel or YMel-1 bacteria was seen with RMA-S cells (15.2% ± 3.7% and
11.8% ± 6.0%, respectively; P > 0.1). The inability of
curliated YMel to interact with RMA-S cells demonstrates that
autoaggregation of the bacteria is not responsible for the interaction
between YMel and RMA cells. Clearly, MHC-I molecules as well as curli
are required for the interactions, as demonstrated by the observation
that noncurliated YMel-1 binds relatively poorly to either RMA or RMA-S
cells (Fig. 5). In addition, the two cell lines bind YMel-1 to the same
degree (14.3% ± 3.8%) [RMA] and 11.8% ± 6.0% [RMA-S];
P > 0.3). These results demonstrate that E. coli expressing curli can interact with host cells through MHC-I
molecules.
|
| |
DISCUSSION |
|---|
|
|
|---|
This report demonstrates for the first time an interaction between purified monomeric MHC-I molecules and a bacterial surface protein. Such an interaction should have several biological implications and not only influence adherence and colonization but also possibly interfere with peptide-MHC-I interactions and alter T-cell receptor recognition of peptide-MHC-I complexes. In contrast to bacterial superantigens, which bind directly to MHC-II molecules and activate T cells in an antigen-independent manner (25), curli showed no significant affinity for the detergent-solubilized MHC-II antigens used here.
The structural gene encoding the curlin subunit is present in most wild-type isolates of E. coli, but the level of expression varies considerably between different isolates and clinical types (23). For example, in the so-called EcoR collection (22), a set of natural E. coli isolates from different sources, approximately 20% of the strains expressed curli at both 26 and 37°C (23), and many enterohemorrhagic, enterotoxigenic, and sepsis isolates express curli at 26°C and retain low expression of curli when grown at 37°C in vitro (3). Enteroinvasive and enteropathogenic isolates, on the other hand, express little or no curli at either temperature (3). Thin aggregative fimbriae (8) are fibrous surface proteins in S. enteritidis closely related to curli, and some strains of Salmonella typhimurium also express these proteins at high levels at 37°C in vitro (26a). Although not yet formally demonstrated, observations of this kind support the notion that curli could indeed be expressed by E. coli growing in vivo, where the environmental conditions and selective pressures are considerably different from in vitro conditions. As mentioned above, the binding of MHC-I molecules to insoluble curli aggregates is the same at room temperature and at 37°C. Thus, once expressed, curli will have the capacity to interact with MHC-I molecules at physiological temperatures.
It has been shown that curliated E. coli as well as purified curlin subunit can bind a number of different human proteins. Interestingly, these proteins have no common structural or functional properties explaining their affinity for curli, suggesting that the curli polymer may have a unique ability to form multiple protein-binding regions with different specificities. This hypothesis is supported by inhibition experiments of this and previous investigations, demonstrating that the binding of a given protein to curli is not blocked by the simultaneous presence of other curli-interacting proteins. The remarkable ability of curli to specifically interact with a variety of host proteins should greatly facilitate the adaptation of curliated E. coli to different ecological niches. Thus, the binding to proteins like fibronectin and laminin (23, 24) may mediate interactions with cells and the cellular matrix. Furthermore, it has been demonstrated that curliated E. coli in human plasma absorbs plasminogen and tissue plasminogen activator, leading to the formation of proteolytically active plasmin (26), which may promote bacterial spreading through tissue degradation. Moreover, in the plasma environment, the proteins of the contact-phase system are assembled at the surface of curliated E. coli, resulting in the release of bradykinin (3). This potent proinflammatory peptide induces vasodilatation and increases vascular permeability and leakage of plasma, which could also contribute to the spread of the infection as well as provide growing bacteria with nutrients.
MHC-I molecules are expressed at the surface of almost all nucleated human cells, and the demonstration here that E. coli is capable of interacting with MHC-I molecules represents yet another protein-binding property of curli which could also influence the host-microbe relationship. Wild-type E. coli expresses curli at high levels in vitro when grown in poor media at temperatures below 30°C (2, 24), suggesting that E. coli infecting a new host may have a high density of curli. The interaction with MHC-I molecules should therefore facilitate initial adherence and colonization. The observation that E. coli growing on solid medium expresses more curli than when growing in liquid medium also indicates an adhesive role for curli. Depending on the type of host cells curliated E. coli is interacting with via MHC-I molecules, this could have different consequences. However, the significance of the interaction described here lies in the fact that MHC-I molecules are abundantly expressed and thus will be available for curli interactions in every possible niche of a mammalian host.
| |
ACKNOWLEDGMENTS |
|---|
This work was supported by grants from Swedish Medical Research Council (projects 7480, 11196, and 11223); the Swedish Natural Science Research Council (project 10610-301); the Royal Physiografic Society; the foundations of Crafoord, Kocks, Schybergs, Zoégas, and Österlund; the Göran Gustafsson Foundation for Research in Natural Sciences and Medicine; ACTINOVA Ltd.; and the Medical Faculty, Lund University.
Ulla Johannesson and Ingbritt Gustafsson are acknowledged for excellent technical assistance.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Cell and Molecular Biology, Section for Molecular Pathogenesis, Lund University, Box 94, S-221 00 Lund, Sweden. Phone: (0)46-222 85 92. Fax: (0)46 15 77 56. E-mail: arne.olsen{at}medkem.lu.se.
Editor: P. E. Orndorff
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Arnqvist, A.,
A. Olsén, and S. Normark.
1994.
s-dependent growth-phase induction of the csgBA promoter in Escherichia coli can be achieved in vivo by 70 in the absence of nucleoid-associated protein H-NS.
Mol. Microbiol.
13:1021-1032[Medline].
|
| 2. | Arnqvist, A., A. Olsén, J. Pfeifer, D. G. Russell, and S. Normark. 1992. The Crl protein activates cryptic genes for curli formation and fibronectin binding in Escherichia coli HB101. Mol. Microbiol. 6:2443-2452[Medline]. |
| 3. | Ben Nasr, A., A. Olsén, U. Sjöbring, W. Müller-Esterl, and L. Björck. 1996. Assembly of human contact phase proteins and release of bradykinin at the surface of curli-expressing Escherichia coli. Mol. Microbiol. 20:927-935[Medline]. |
| 4. |
Berggård, I., and A. G. Bearn.
1968.
Isolation and properties of a low molecular weight 2-globulin occurring in human biological fluids.
J. Biol. Chem.
243:4095-4103 |
| 5. | Bjorkman, P. J., M. A. Saper, B. Samraoui, W. S. Bennett, J. L. Strominger, and D. C. Wiley. 1987. Structure of the human class I histocompatibility antigen, HLA-A2. Nature 329:506-512[Medline]. |
| 6. |
Collinson, S. K.,
S. C. Clouthier,
J. L. Doran,
P. A. Banser, and W. W. Kay.
1996.
Salmonella enteritidis agfBAC operon encoding thin, aggregative fimbriae.
J. Bacteriol.
178:662-667 |
| 7. |
Collinson, S. K.,
P. C. Doig,
J. L. Doran,
S. Clouthier,
T. J. Trust, and W. W. Kay.
1993.
Thin, aggregative fimbriae mediate binding of Salmonella enteritidis to fibronectin.
J. Bacteriol.
175:12-18 |
| 8. |
Collinson, S. K.,
L. Emödy,
K.-H. Müller,
T. J. Trust, and W. W. Kay.
1991.
Purification and characterization of thin, aggregative fimbriae from Salmonella enteritidis.
J. Bacteriol.
173:4773-4781 |
| 9. |
Collinson, S. K.,
L. Emödy,
T. J. Trust, and W. W. Kay.
1992.
Thin aggregative fimbriae from diarrheagenic Escherichia coli.
J. Bacteriol.
174:4490-4495 |
| 10. |
Doran, J. L.,
S. K. Collinson,
J. Burian,
G. Sarlós,
E. C. D. Todd,
C. K. Munro,
C. M. Kay,
P. A. Banser,
P. I. Peterkin, and W. W. Kay.
1993.
DNA-based diagnostic tests for Salmonella species targeting agfA, the structural gene for thin aggregative fimbriae.
J. Clin. Microbiol.
31:2263-2273 |
| 11. |
Dorval, G.,
K. I. Welsh,
K. Nilsson, and H. Wigzell.
1977.
Quantitation of 2-microglobulin and HLA on the surface of human cells. I. T and B lymphocytes and lymphoblasts.
Scand. J. Immunol.
6:255-263[Medline].
|
| 12. |
Evans, D. G.,
D. J. Evans, and W. Tjoa.
1977.
Hemagglutination of human group A erythrocytes by enterotoxigenic Escherichia coli isolated from adults with diarrhea: correlation with colonization factor.
Infect. Immun.
18:330-337 |
| 13. |
Evrin, P. E., and H. Pertoft.
1973.
2-Microglobulin in human blood cells.
J. Immunol.
111:1147-1154 |
| 14. | Germain, R. N., and D. H. Margulies. 1993. The biochemistry and cell biology of antigen processing and presentation. Annu. Rev. Immunol. 11:403-450[Medline]. |
| 15. | Hammar, M., A. Arnqvist, Z. Bian, A. Olsén, and S. Normark. 1995. Expression of two csg operons is required for production of fibronectin- and Congo red-binding curli polymers in Escherichia coli K-12. Mol. Microbiol. 18:661-670[Medline]. |
| 16. |
Hammar, M.,
Z. Bian, and S. Normark.
1996.
Nucleator-dependent intercellular assembly of adhesive curli organelles in Escherichia coli.
Proc. Natl. Acad. Sci. USA
93:6562-6566 |
| 17. | Hunter, W. M., and F. C. Greenwood. 1962. Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature 194:495-496[Medline]. |
| 18. | Kehoe, M. A. 1994. Cell-wall-associated proteins in Gram-positive bacteria, p. 217-261. In J.-M. Ghuysen, and R. Hakenbeck (ed.), Bacterial cell wall, vol. 27. Elsevier, Amsterdam, The Netherlands. |
| 19. | Klareskog, L., L. Trägårdh, L. Rask, and P. A. Peterson. 1979. Isolation and characterization of detergent-solubilized human HLA-DR transplantation antigens. Biochemistry 18:1481-1489[Medline]. |
| 20. | Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685[Medline]. |
| 21. | Ljunggren, H. G., N. J. Stam, C. Öhlén, J. J. Neefjes, P. Höglund, M.-T. Heemels, J. Bastin, T. N. M. Schumacher, A. Townsend, K. Kärre, and H. L. Ploegh. 1990. Empty MHC class I molecules come out in the cold. Nature 346:476-480[Medline]. |
| 22. |
Ochman, H., and R. K. Selander.
1984.
Standard reference strains from Escherichia coli from natural populations.
J. Bacteriol.
157:690-693 |
| 23. | Olsén, A., A. Arnqvist, M. Hammar, S. Sukupolvi, and S. Normark. 1993. The RpoS sigma factor relieves H-NS-mediated transcriptional repression of csgA, the subunit gene of fibronectin binding curli in Escherichia coli. Mol. Microbiol. 7:523-536[Medline]. |
| 24. | Olsén, A., A. Jonsson, and S. Normark. 1989. Fibronectin binding mediated by a novel class of surface organelles on Escherichia coli. Nature 338:652-655[Medline]. |
| 25. | Scherer, M. T., L. Ignatowicz, G. M. Winslow, J. W. Kappler, and P. Marrack. 1993. Superantigens: bacterial and viral proteins that manipulate the immune system. Annu. Rev. Cell Biol. 9:101-128. |
| 26. | Sjöbring, U., G. Pohl, and A. Olsén. 1994. Plasminogen, absorbed by Escherichia coli expressing curli or by Salmonella enteritidis expressing thin aggregative fimbriae, can be activated by simultaneously captured tissue-type plasminogen activator (t-PA). Mol. Microbiol. 14:443-452[Medline]. |
| 26a. | Sukupolvi, S., A. Edelstein, M. Rhen, S. J. Normark, and J. D. Pfeifer. 1997. Development of a murine model of chronic Salmonella infection. Infect. Immun. 65:838-842[Abstract]. |
| 27. | Trägårdh, L., B. Curman, K. Wiman, L. Rask, and P. A. Peterson. 1979. Chemical, physical-chemical, and immunological properties of papain-solubilized human transplantation antigens. Biochemistry 18:2218-2226[Medline]. |
| 28. |
Williams, A. F., and A. N. Barclay.
1988.
The immunoglobulin superfamily domains for cell surface recognition.
Annu. Rev. Immunol.
6:381-405[Medline].
|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|